Sambuceti G, Brignone M, Marini C, Massollo M, Fiz F, Morbelli S
Eur J Nucl Med Mol Imaging. 2012; 39(8):1326-38.
PMID: 22639281
DOI: 10.1007/s00259-012-2141-9.
Agool A, Glaudemans A, Boersma H, Dierckx R, Vellenga E, Slart R
Eur J Nucl Med Mol Imaging. 2010; 38(1):166-78.
PMID: 20625724
PMC: 3005118.
DOI: 10.1007/s00259-010-1531-0.
Almers S, Granerus G, Franzen L, Strom M
Eur J Nucl Med. 1996; 23(3):247-55.
PMID: 8599955
DOI: 10.1007/BF00837622.
Wu S, Bazar L, COHN M, Cahill R, Chan W
Mol Cell Biochem. 1993; 122(2):147-58.
PMID: 8232246
DOI: 10.1007/BF01076099.
Frenoy N, Berruel C, Child J, Gendron M, Missett J, Razafimahaleo E
Br J Cancer. 1982; 46(5):765-72.
PMID: 6756460
PMC: 2011169.
DOI: 10.1038/bjc.1982.269.
Demonstration of carcinoembryonic antigen in bone marrow from patients with carcinoma.
Gray A, Downing R, Hill R, Payne R, WINDSOR C
J Clin Pathol. 1984; 37(10):1090-4.
PMID: 6386889
PMC: 498945.
DOI: 10.1136/jcp.37.10.1090.
Serum NCA in bone marrow transplant recipients and its metabolism.
Gadler F, Wahren B
Med Oncol Tumor Pharmacother. 1985; 2(4):281-5.
PMID: 3910975
DOI: 10.1007/BF02934914.
Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series.
Noworolska A, Harlozinska A, Richter R, Brodzka W
Br J Cancer. 1985; 51(3):371-7.
PMID: 3882113
PMC: 1976944.
DOI: 10.1038/bjc.1985.49.
Relationship between myelomonocytic, myeloid and nonspecific cross-reacting (NCA) antigens during myelocytic cell differentiation.
Harlozinska A, Noworolska A, Majdic O, Richter R, Kotlarek-Haus S
Br J Cancer. 1987; 56(6):787-90.
PMID: 2449236
PMC: 2002402.
DOI: 10.1038/bjc.1987.289.
Recent advances in bone marrow scanning.
Reske S
Eur J Nucl Med. 1991; 18(3):203-21.
PMID: 2040342
DOI: 10.1007/BF02262732.
Reduced technetium 99m labelled NCA-95/CEA-antibody uptake in liver due to gentle antibody reconstitution. Technical note.
Reske S, Buell U
Eur J Nucl Med. 1990; 17(1-2):38-41.
PMID: 1964640
DOI: 10.1007/BF00819402.
